What are we trying to establish?
Name the clinical or commercial question, and the population, asset, or event it concerns.
- Context
- Question, population, asset, or event
Women's health
Lacuna is a public-source research workspace for connecting clinical evidence, company events, financing, ownership, and strategic outcomes. Start with a question; you do not need to understand every dashboard.
If you are evaluating a company
Start with Deals
Follow a transaction, sources, comparable context, and what was knowable.
If you are investigating the science
Start with Research
Move from clinical trials and evidence maturity to population context.
If you want to audit the system
Start with Methods
See coverage, record quality, timing, and the limits of the dataset.
61 verified deals — SEC EDGAR ingest · HIPAA/GDPR genomics layer · descriptive analytics only. Not PitchBook, not live market feeds, and not investment advice.
How to read Lacuna
Treat the interface as a research trail, not a single score. Observed facts, derived context, and unresolved questions should remain visibly different.
Evidence
What a cited public source directly supports.
Interpretation
What can be derived or compared from those observations.
Uncertainty
What is missing, weakly observed, or still requires diligence.
Evidence architecture
Source-verified observations, analytical interpretation, explicit uncertainty, and decision implications stay distinct.
Name the clinical or commercial question, and the population, asset, or event it concerns.
Separate what a cited source states from what analysis infers.
A bounded conclusion or next diligence step. It does not turn interpretation into fact.
101
Companies in our network
53
Verified deals
$21.0B
WH disclosed value (completed)
322
Public sources cited
HLTH/Outcomes4Me 2022 (breast cancer, n=1,828): max gap 80/100 (presented with clinical trial as treatment option). Weighted burden 52/100 · median 48/100 · 2 critical. Top priority: patients with full access to medical records ( score 51). Weakest prerequisite: evidence-based standards presented.
Cited 2022 survey — not live Lacuna patient data →
Prior-auth friction, avoidable admin waste, and VC investment signals for payer-aligned women's health deals — built for payer corporate venture context.
Use the Workspaces menu above when you already know where you are going. Use these cards when you want a plain-English explanation first.
Wearables, wellness apps, and consumer digital health M&A — separate from medicine & biotech.
Network graph, deal flow, valuation matrix, and acquirer landscape.
Prior-auth friction, claims ops waste, and VC investment signals for payer-aligned women's health deals.
Clinical trials, evidence maturity, genomics, health equity, and patient empowerment baselines.
Record quality, observed sector composition, and announcement timing.
Reimbursement context, historical acquirer-profile overlap, and dataset export.